Zhejiang Haisen Pharmaceutical Co., Ltd. (SHE:001367)
17.70
+0.23 (1.32%)
At close: Jul 31, 2026
SHE:001367 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 520.97 | 532.26 | 471.51 | 397.45 | 422.78 | 388.98 |
Revenue Growth | 9.87% | 12.88% | 18.63% | -5.99% | 8.69% | 36.58% |
Gross Profit Gross Profit Growth | 240.29 | 241.02 | 189.6 | 160.05 | 156.26 | 152.87 |
Operating Income Operating Income Growth | 141.99 | 142.61 | 116.72 | 100.9 | 105.02 | 105.02 |
Net Income Net Income Growth | 133.58 | 135.88 | 122.56 | 104.67 | 107.59 | 94 |
Earnings Per Share EPS Growth | 0.88 | 0.89 | 0.82 | 0.76 | 0.96 | 0.84 |
EPS Growth | 10.48% | 8.54% | 7.40% | -20.74% | 14.68% | 49.60% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
China China Growth | 242.03 | 234.5 | 185.4 | 228.33 | 199.72 |
Overseas Overseas Growth | 290.23 | 237.01 | 212.06 | 194.45 | 187.07 |
Total Total Growth | 532.26 | 471.51 | 397.45 | 422.78 | 388.98 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,070 | 1,061 | 1,034 | 943.75 | 247.19 | 206 |
Total Debt Total Debt Growth | 7.51 | 7.43 | 8.12 | 0.17 | 0.78 | 1.53 |
Net Cash (Debt) Net Cash Growth | 1,062 | 1,054 | 1,026 | 943.59 | 246.41 | 204.47 |
Net Cash Growth | 4.06% | 2.67% | 8.77% | 282.94% | 20.51% | 46.15% |
Net Cash Per Share Net Cash Per Share Growth | 7.00 | 6.90 | 6.87 | 6.88 | 2.21 | 1.83 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 163.28 | 177.45 | 167.16 | 80.62 | 74.95 | 107.04 |
Capital Expenditures CapEx Growth | -114.38 | -152.26 | -64.75 | -57.44 | -20.19 | -33.32 |
Free Cash Flow Free Cash Flow Growth | 48.9 | 25.19 | 102.41 | 23.17 | 54.76 | 73.72 |
Free Cash Flow Growth | -45.01% | -75.40% | 341.91% | -57.68% | -25.73% | 32.89% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Gross Margin | 46.12% | 45.28% | 40.21% | 40.27% | 36.96% | 39.30% |
Operating Margin | 27.25% | 26.79% | 24.75% | 25.39% | 24.84% | 27.00% |
Pretax Margin | 29.51% | 29.45% | 30.07% | 30.36% | 29.28% | 27.90% |
Profit Margin | 25.64% | 25.53% | 25.99% | 26.33% | 25.45% | 24.16% |
FCF Margin | 9.38% | 4.73% | 21.72% | 5.83% | 12.95% | 18.95% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Dividend Per Share Dividend Per Share Growth | 0.116 | 0.116 | 0.170 | 0.228 |
Dividend Per Share Growth | -31.76% | -31.77% | -25.50% | - |
Dividend Yield | 0.66% | 0.53% | 0.93% | 1.16% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
PE Ratio | 20.10 | 24.29 | 22.82 | 28.56 | - | - |
P/FCF Ratio | 54.42 | 131.00 | 27.31 | 128.99 | - | - |
PS Ratio | 5.11 | 6.20 | 5.93 | 7.52 | - | - |